Fenofibrate cholesterol lowering intervention
systematic review meta-analysis network meta-analysis
 

Procetofen      

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathstroke (fatal and non fatal)

cardiovascular prevention  

FIELD, 2005             fenofibrateplacebodiabetic type 2 diabetes Low risk of bias suggesting 10%-10%
FIELD, 2005     fenofibrateplacebodiabetic patientsLow risk of bias suggesting10%-10%
DAIS, 2001     fenofibrateplacebodiabetic type 2 diabetes Exploratory negative-32%
ACCORD lipid, 2010    NCTfenofibrateplacebo (on top simvastatine)diabetic patientsLow risk of bias negative-9%6%

diabetes type 2  

FIELD, 2005     fenofibrateplacebodiabetic patientsLow risk of bias suggesting10%-10%
ACCORD lipid, 2010    NCTfenofibrateplacebo (on top simvastatine)diabetic patientsLow risk of bias negative-9%6%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons